Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04050722 · ClinicalTrials.gov registry record · Phase 4

A Clinical Study Investigating the Efficacy of a Stannous Fluoride Dentifrice in Improving Gingival Health After Twice Daily Use for 3 Weeks

A Phase 4 study, sponsored by GlaxoSmithKline.

Completed
Registry status
Phase 4
Development phase
130
Enrollment target

NCT04050722 is a Phase 4 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 130 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04050722, a Phase 4 study, has completed, sponsored by GlaxoSmithKline.

COMPLETED
Registry status
Phase 4
Development phase
130 participants
Enrollment target

Study Summary

The aim of this study is to investigate the impact of a stannous fluoride containing toothpaste in reducing gingivitis when used twice daily for a maximum for 3 weeks, when compared to a standard sodium fluoride toothpaste (negative control).

Interventions

  • DRUG Colgate Cavity Protection
  • DRUG Sensodyne Repair and Protect

Trial Details

FieldValue
Enrollment Target 130 participants
Start Date 2019-10-07
Est. Completion 2019-11-13
Phase Phase 4

Sponsor

GlaxoSmithKline

1,345 total trials

What the Registry Record Tells You About NCT04050722

The ClinicalTrials.gov registry entry for NCT04050722 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Colgate Cavity Protection is the first listed.

NCT04050722 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04050722 about?

NCT04050722 is a clinical study titled "A Clinical Study Investigating the Efficacy of a Stannous Fluoride Dentifrice in Improving Gingival Health After Twice Daily Use for 3 Weeks". The aim of this study is to investigate the impact of a stannous fluoride containing toothpaste in reducing gingivitis when used twice daily for a maximum for 3 weeks, when compared to a standard sodium fluoride toothpaste (negative control).

What is the current status of trial NCT04050722?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 130 participants. The study started on 2019-10-07. Estimated completion is 2019-11-13.

What interventions are being tested in trial NCT04050722?

The interventions under investigation include: Colgate Cavity Protection (DRUG), Sensodyne Repair and Protect (DRUG).

Who is sponsoring clinical trial NCT04050722?

This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.